The place of high-dose therapy with autologous stem cell transplantation in primary treatment of Hodgkin's disease.
Carella
A M
AM
Autologous BMT Unit, Ospedale S. Martino, Genoa, Italy.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D012307:Risk Factors; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents